FinTechFunding

InhaleRx: Appoints Darryl Davies as CEO

InhaleRx Appoints Darryl Davies as CEO

  • Healthcare and technology company InhaleRx (IRX) appoints Darryl Davies as CEO, effective immediately
  • Mr Davies joined the company’s board in July 2021 and has over 16 years of experience in psychology, harm minimisation and healthcare commercialisation
  • He launched Australia’s first university-partnered educational programs for the cannabis industry and has coordinated doctor education initiative across Australia
  • Further, Dr Rob Jenny has been appointed Chief Scientific Officer while Dr John Crock has been appointed Non-Executive Director
  • The company is up 6.67 per cent on the market with shares trading at 6.4 cents at 1:53 pm AEST
Previous article
Australian Agricultural Company: Appoints David Harris as CEO and MD
Next article
Strike Energy: Releases independent reserve certification of South Erregulla, WA
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NatWest Group Strengthens Free Investment Guidance Programme

New initiative aims to educate more customers on investing.Highlights: NatWest Group expands free investment guidance programme.Initiative targets educating...
FinTech

Tether Launches New Stablecoin Wallet to Enhance User Experience

This innovative platform aims to improve accessibility for crypto users.Highlights: Tether has introduced a new stablecoin wallet.The wallet...
FinTech

FCA Strengthens Money Laundering Combat with Synthetic Dataset

New collaboration aims to enhance detection capabilities against financial crime.Highlights: FCA partners with Turing Institute to combat money...
FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...